APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vasodilators

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Vasodilators Industry Growth and Trends Forecast to 2032

20 December 2025102 pages

Choose your research edition.

Industry ResearchVasodilators Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Vasodilators Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Vasodilators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vasodilators Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Vasodilators Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Vasodilators market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Vasodilators is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Vasodilators is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vasodilators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vasodilators include Teva Pharmaceutical, Sanofi, Jhonson and Johnson, Novartis, Merck, Eli Lilly, Pfizer, GSK and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Vasodilators market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Vasodilators market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vasodilators market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vasodilators.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Vasodilators market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Vasodilators Market by Company

Teva Pharmaceutical

Sanofi

Jhonson and Johnson

Novartis

Merck

Eli Lilly

Pfizer

GSK

Bayer

Bristol-Myers Squibb

Astra Zeneca

Vasodilators Segment by Type

Venous Dilators

Mixed Dilators

Arterial Dilators

Vasodilators Segment by Application

Heart Failure

Angina

Hypertension

Vasodilators Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vasodilators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vasodilators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vasodilators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vasodilators manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Vasodilators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Venous Dilators Table 2. Major Company of Mixed Dilators Table 3. Major Company of Arterial Dilators Table 4. Global Vasodilators Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Vasodilators Sales by Type (2021-2026) & (k tons) Table 6. Global Vasodilators Sales Market Share in Volume by Type (2021-2026) Table 7. Global Vasodilators Sales by Type (2021-2026) & (US$ Million) Table 8. Global Vasodilators Sales Market Share in Value by Type (2021-2026) Table 9. Global Vasodilators Price by Type (2021-2026) & (US$/ton) Table 10. Global Vasodilators Sales by Type (2027-2032) & (k tons) Table 11. Global Vasodilators Sales Market Share in Volume by Type (2027-2032) Table 12. Global Vasodilators Sales by Type (2027-2032) & (US$ Million) Table 13. Global Vasodilators Sales Market Share in Value by Type (2027-2032) Table 14. Global Vasodilators Price by Type (2027-2032) & (US$/ton) Table 15. North America Vasodilators Sales by Type (2021-2026) & (k tons) Table 16. North America Vasodilators Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Vasodilators Sales by Type (2021-2026) & (k tons) Table 18. Europe Vasodilators Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Vasodilators Sales by Type (2021-2026) & (k tons) Table 20. Asia-Pacific Vasodilators Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Vasodilators Sales by Type (2021-2026) & (k tons) Table 22. Latin America Vasodilators Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Vasodilators Sales by Type (2021-2026) & (k tons) Table 24. Middle East and Africa Vasodilators Sales by Type (2021-2026) & (US$ Million) Table 25. Vasodilators Industry Trends Table 26. Vasodilators Industry Drivers Table 27. Vasodilators Industry Opportunities and Challenges Table 28. Vasodilators Industry Restraints Table 29. Global Vasodilators Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Vasodilators Revenue Market Share by Company (2021-2026) Table 31. Global Vasodilators Sales by Company (2021-2026) & (k tons) Table 32. Global Vasodilators Sales Share by Company (2021-2026) Table 33. Global Vasodilators Market Price by Company (2021-2026) & (US$/ton) Table 34. Global Vasodilators Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Vasodilators Major Company Production Sites and Headquarters Table 36. Global Vasodilators Company, Product Type & Application Table 37. Global Vasodilators Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Vasodilators by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Vasodilators Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Vasodilators Sales by Region (2021-2026) & (k tons) Table 42. Global Vasodilators Sales Market Share in Volume by Region (2021-2026) Table 43. Global Vasodilators Sales by Region (2021-2026) & (US$ Million) Table 44. Global Vasodilators Sales Market Share in Value by Region (2021-2026) Table 45. Global Vasodilators Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 46. Global Vasodilators Sales by Region (2027-2032) & (k tons) Table 47. Global Vasodilators Sales Market Share in Volume by Region (2027-2032) Table 48. Global Vasodilators Sales by Region (2027-2032) & (US$ Million) Table 49. Global Vasodilators Sales Market Share in Value by Region (2027-2032) Table 50. Global Vasodilators Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 51. Global Vasodilators Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Vasodilators Sales by Application (2021-2026) & (k tons) Table 53. Global Vasodilators Sales Market Share in Volume by Application (2021-2026) Table 54. Global Vasodilators Sales by Application (2021-2026) & (US$ Million) Table 55. Global Vasodilators Sales Market Share in Value by Application (2021-2026) Table 56. Global Vasodilators Price by Application (2021-2026) & (US$/ton) Table 57. Global Vasodilators Sales by Application (2027-2032) & (k tons) Table 58. Global Vasodilators Sales Market Share in Volume by Application (2027-2032) Table 59. Global Vasodilators Sales by Application (2027-2032) & (US$ Million) Table 60. Global Vasodilators Sales Market Share in Value by Application (2027-2032) Table 61. Global Vasodilators Price by Application (2027-2032) & (US$/ton) Table 62. North America Vasodilators Sales by Application (2021-2026) & (k tons) Table 63. North America Vasodilators Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Vasodilators Sales by Application (2021-2026) & (k tons) Table 65. Europe Vasodilators Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Vasodilators Sales by Application (2021-2026) & (k tons) Table 67. Asia-Pacific Vasodilators Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Vasodilators Sales by Application (2021-2026) & (k tons) Table 69. Latin America Vasodilators Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Vasodilators Sales by Application (2021-2026) & (k tons) Table 71. Middle East and Africa Vasodilators Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Pharmaceutical Company Information Table 73. Teva Pharmaceutical Business Overview Table 74. Teva Pharmaceutical Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 75. Teva Pharmaceutical Vasodilators Product Portfolio Table 76. Teva Pharmaceutical Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 80. Sanofi Vasodilators Product Portfolio Table 81. Sanofi Recent Development Table 82. Jhonson and Johnson Company Information Table 83. Jhonson and Johnson Business Overview Table 84. Jhonson and Johnson Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 85. Jhonson and Johnson Vasodilators Product Portfolio Table 86. Jhonson and Johnson Recent Development Table 87. Novartis Company Information Table 88. Novartis Business Overview Table 89. Novartis Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 90. Novartis Vasodilators Product Portfolio Table 91. Novartis Recent Development Table 92. Merck Company Information Table 93. Merck Business Overview Table 94. Merck Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 95. Merck Vasodilators Product Portfolio Table 96. Merck Recent Development Table 97. Eli Lilly Company Information Table 98. Eli Lilly Business Overview Table 99. Eli Lilly Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 100. Eli Lilly Vasodilators Product Portfolio Table 101. Eli Lilly Recent Development Table 102. Pfizer Company Information Table 103. Pfizer Business Overview Table 104. Pfizer Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 105. Pfizer Vasodilators Product Portfolio Table 106. Pfizer Recent Development Table 107. GSK Company Information Table 108. GSK Business Overview Table 109. GSK Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 110. GSK Vasodilators Product Portfolio Table 111. GSK Recent Development Table 112. Bayer Company Information Table 113. Bayer Business Overview Table 114. Bayer Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 115. Bayer Vasodilators Product Portfolio Table 116. Bayer Recent Development Table 117. Bristol-Myers Squibb Company Information Table 118. Bristol-Myers Squibb Business Overview Table 119. Bristol-Myers Squibb Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 120. Bristol-Myers Squibb Vasodilators Product Portfolio Table 121. Bristol-Myers Squibb Recent Development Table 122. Astra Zeneca Company Information Table 123. Astra Zeneca Business Overview Table 124. Astra Zeneca Vasodilators Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 125. Astra Zeneca Vasodilators Product Portfolio Table 126. Astra Zeneca Recent Development Table 127. North America Vasodilators Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 128. North America Vasodilators Sales by Country (2021-2026) & (k tons) Table 129. North America Vasodilators Sales Market Share by Country (2021-2026) Table 130. North America Vasodilators Sales Forecast by Country (2027-2032) & (k tons) Table 131. North America Vasodilators Sales Market Share Forecast by Country (2027-2032) Table 132. North America Vasodilators Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Vasodilators Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Vasodilators Market Share by Country (2021-2026) Table 135. North America Vasodilators Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Vasodilators Market Share Forecast by Country (2027-2032) Table 137. Europe Vasodilators Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 138. Europe Vasodilators Sales by Country (2021-2026) & (k tons) Table 139. Europe Vasodilators Sales Market Share by Country (2021-2026) Table 140. Europe Vasodilators Sales Forecast by Country (2027-2032) & (k tons) Table 141. Europe Vasodilators Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Vasodilators Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Vasodilators Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Vasodilators Market Share by Country (2021-2026) Table 145. Europe Vasodilators Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Vasodilators Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Vasodilators Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Vasodilators Sales by Country (2021-2026) & (k tons) Table 149. Asia-Pacific Vasodilators Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Vasodilators Sales Forecast by Country (2027-2032) & (k tons) Table 151. Asia-Pacific Vasodilators Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Vasodilators Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Vasodilators Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Vasodilators Market Share by Country (2021-2026) Table 155. Asia-Pacific Vasodilators Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Vasodilators Market Share Forecast by Country (2027-2032) Table 157. Latin America Vasodilators Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 158. Latin America Vasodilators Sales by Country (2021-2026) & (k tons) Table 159. Latin America Vasodilators Sales Market Share by Country (2021-2026) Table 160. Latin America Vasodilators Sales Forecast by Country (2027-2032) & (k tons) Table 161. Latin America Vasodilators Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Vasodilators Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Vasodilators Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Vasodilators Market Share by Country (2021-2026) Table 165. Latin America Vasodilators Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Vasodilators Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Vasodilators Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Vasodilators Sales by Country (2021-2026) & (k tons) Table 169. Middle East and Africa Vasodilators Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Vasodilators Sales Forecast by Country (2027-2032) & (k tons) Table 171. Middle East and Africa Vasodilators Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Vasodilators Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Vasodilators Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Vasodilators Market Share by Country (2021-2026) Table 175. Middle East and Africa Vasodilators Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Vasodilators Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Vasodilators Distributors List Table 180. Vasodilators Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Vasodilators Image Figure 2. Global Vasodilators Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vasodilators Market Size (2021-2032) & (US$ Million) Figure 4. Global Vasodilators Sales (2021-2032) & (k tons) Figure 5. Venous Dilators Image Figure 6. Global Venous Dilators Sales YoY Growth (2021-2032) & (k tons) Figure 7. Mixed Dilators Image Figure 8. Global Mixed Dilators Sales YoY Growth (2021-2032) & (k tons) Figure 9. Arterial Dilators Image Figure 10. Global Arterial Dilators Sales YoY Growth (2021-2032) & (k tons) Figure 11. Global Vasodilators Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Vasodilators Market Share by Type 2025 VS 2032 Figure 13. North America Vasodilators Sales Market Share in Volume by Type in 2025 Figure 14. North America Vasodilators Sales Market Share in Value by Type in 2025 Figure 15. Europe Vasodilators Sales Market Share in Volume by Type in 2025 Figure 16. Europe Vasodilators Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Vasodilators Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Vasodilators Sales Market Share in Value by Type in 2025 Figure 19. Latin America Vasodilators Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Vasodilators Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Vasodilators Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Vasodilators Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Vasodilators Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Heart Failure Image Figure 26. Global Heart Failure Sales YoY Growth (2021-2032) & (k tons) Figure 27. Angina Image Figure 28. Global Angina Sales YoY Growth (2021-2032) & (k tons) Figure 29. Hypertension Image Figure 30. Global Hypertension Sales YoY Growth (2021-2032) & (k tons) Figure 31. Global Vasodilators Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Vasodilators Market Share by Application 2025 VS 2032 Figure 33. North America Vasodilators Sales Market Share in Volume by Application in 2025 Figure 34. North America Vasodilators Sales Market Share in Value by Application in 2025 Figure 35. Europe Vasodilators Sales Market Share in Volume by Application in 2025 Figure 36. Europe Vasodilators Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Vasodilators Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Vasodilators Sales Market Share in Value by Application in 2025 Figure 39. Latin America Vasodilators Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Vasodilators Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Vasodilators Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Vasodilators Sales Market Share in Value by Application in 2025 Figure 43. North America Vasodilators Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 44. North America Vasodilators Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Vasodilators Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Vasodilators Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Vasodilators Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 48. Europe Vasodilators Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Vasodilators Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Vasodilators Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Vasodilators Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 52. Asia-Pacific Vasodilators Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Vasodilators Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Vasodilators Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Vasodilators Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 56. Latin America Vasodilators Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Vasodilators Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Vasodilators Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Vasodilators Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 60. Middle East and Africa Vasodilators Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Vasodilators Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Vasodilators Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Vasodilators Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Vasodilators Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Venous Dilators
  • Mixed Dilators
  • Arterial Dilators
Applications
  • Heart Failure
  • Angina
  • Hypertension
Companies covered
  • Teva Pharmaceutical
  • Sanofi
  • Jhonson and Johnson
  • Novartis
  • Merck
  • Eli Lilly
  • Pfizer
  • GSK
  • Bayer
  • Bristol-Myers Squibb
  • Astra Zeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vasodilators Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Vasodilators Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Vasodilators Market by Type
  6. 1.3.1 Venous Dilators
  7. 1.3.2 Mixed Dilators
  8. 1.3.3 Arterial Dilators
  9. 1.4 Global Vasodilators Market Size by Type
  10. 1.4.1 Global Vasodilators Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Vasodilators Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Vasodilators Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Vasodilators Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Vasodilators Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Vasodilators Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Vasodilators Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Vasodilators Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Vasodilators Industry Trends
  2. 2.2 Vasodilators Industry Drivers
  3. 2.3 Vasodilators Industry Opportunities and Challenges
  4. 2.4 Vasodilators Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Vasodilators Revenue (2021-2026)
  2. 3.2 Global Top Players by Vasodilators Sales (2021-2026)
  3. 3.3 Global Top Players by Vasodilators Price (2021-2026)
  4. 3.4 Global Vasodilators Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vasodilators Major Company Production Sites & Headquarters
  6. 3.6 Global Vasodilators Company, Product Type & Application
  7. 3.7 Global Vasodilators Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vasodilators Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vasodilators Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vasodilators Tier 1, Tier 2, and Tier 3
4 Vasodilators Regional Status and Outlook
  1. 4.1 Global Vasodilators Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Vasodilators Historic Market Size by Region
  3. 4.2.1 Global Vasodilators Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Vasodilators Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Vasodilators Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Vasodilators Forecasted Market Size by Region
  7. 4.3.1 Global Vasodilators Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Vasodilators Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Vasodilators Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Vasodilators by Application
  1. 5.1 Vasodilators Market by Application
  2. 5.1.1 Heart Failure
  3. 5.1.2 Angina
  4. 5.1.3 Hypertension
  5. 5.2 Global Vasodilators Market Size by Application
  6. 5.2.1 Global Vasodilators Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Vasodilators Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Vasodilators Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Vasodilators Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Vasodilators Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Vasodilators Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Vasodilators Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Vasodilators Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical
  2. 6.1.1 Teva Pharmaceutical Company Information
  3. 6.1.2 Teva Pharmaceutical Business Overview
  4. 6.1.3 Teva Pharmaceutical Vasodilators Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Vasodilators Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Vasodilators Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Vasodilators Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Jhonson and Johnson
  14. 6.3.1 Jhonson and Johnson Company Information
  15. 6.3.2 Jhonson and Johnson Business Overview
  16. 6.3.3 Jhonson and Johnson Vasodilators Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jhonson and Johnson Vasodilators Product Portfolio
  18. 6.3.5 Jhonson and Johnson Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Vasodilators Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Vasodilators Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Merck
  26. 6.5.1 Merck Company Information
  27. 6.5.2 Merck Business Overview
  28. 6.5.3 Merck Vasodilators Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck Vasodilators Product Portfolio
  30. 6.5.5 Merck Recent Developments
  31. 6.6 Eli Lilly
  32. 6.6.1 Eli Lilly Company Information
  33. 6.6.2 Eli Lilly Business Overview
  34. 6.6.3 Eli Lilly Vasodilators Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Eli Lilly Vasodilators Product Portfolio
  36. 6.6.5 Eli Lilly Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Vasodilators Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Vasodilators Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 GSK
  44. 6.8.1 GSK Company Information
  45. 6.8.2 GSK Business Overview
  46. 6.8.3 GSK Vasodilators Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GSK Vasodilators Product Portfolio
  48. 6.8.5 GSK Recent Developments
  49. 6.9 Bayer
  50. 6.9.1 Bayer Company Information
  51. 6.9.2 Bayer Business Overview
  52. 6.9.3 Bayer Vasodilators Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bayer Vasodilators Product Portfolio
  54. 6.9.5 Bayer Recent Developments
  55. 6.10 Bristol-Myers Squibb
  56. 6.10.1 Bristol-Myers Squibb Company Information
  57. 6.10.2 Bristol-Myers Squibb Business Overview
  58. 6.10.3 Bristol-Myers Squibb Vasodilators Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Bristol-Myers Squibb Vasodilators Product Portfolio
  60. 6.10.5 Bristol-Myers Squibb Recent Developments
  61. 6.11 Astra Zeneca
  62. 6.11.1 Astra Zeneca Company Information
  63. 6.11.2 Astra Zeneca Business Overview
  64. 6.11.3 Astra Zeneca Vasodilators Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Astra Zeneca Vasodilators Product Portfolio
  66. 6.11.5 Astra Zeneca Recent Developments
7 North America by Country
  1. 7.1 North America Vasodilators Sales by Country
  2. 7.1.1 North America Vasodilators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Vasodilators Sales by Country (2021-2026)
  4. 7.1.3 North America Vasodilators Sales Forecast by Country (2027-2032)
  5. 7.2 North America Vasodilators Market Size by Country
  6. 7.2.1 North America Vasodilators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Vasodilators Market Size by Country (2021-2026)
  8. 7.2.3 North America Vasodilators Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Vasodilators Sales by Country
  2. 8.1.1 Europe Vasodilators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Vasodilators Sales by Country (2021-2026)
  4. 8.1.3 Europe Vasodilators Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Vasodilators Market Size by Country
  6. 8.2.1 Europe Vasodilators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Vasodilators Market Size by Country (2021-2026)
  8. 8.2.3 Europe Vasodilators Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Vasodilators Sales by Country
  2. 9.1.1 Asia-Pacific Vasodilators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Vasodilators Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Vasodilators Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Vasodilators Market Size by Country
  6. 9.2.1 Asia-Pacific Vasodilators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Vasodilators Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Vasodilators Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Vasodilators Sales by Country
  2. 10.1.1 South America Vasodilators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Vasodilators Sales by Country (2021-2026)
  4. 10.1.3 South America Vasodilators Sales Forecast by Country (2027-2032)
  5. 10.2 South America Vasodilators Market Size by Country
  6. 10.2.1 South America Vasodilators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Vasodilators Market Size by Country (2021-2026)
  8. 10.2.3 South America Vasodilators Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Vasodilators Sales by Country
  2. 11.1.1 Middle East and Africa Vasodilators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Vasodilators Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Vasodilators Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Vasodilators Market Size by Country
  6. 11.2.1 Middle East and Africa Vasodilators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Vasodilators Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Vasodilators Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Vasodilators Value Chain Analysis
  2. 12.1.1 Vasodilators Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Vasodilators Production Mode & Process
  7. 12.2 Vasodilators Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Vasodilators Distributors
  10. 12.2.3 Vasodilators Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst